After the story went viral, two hospitals in eastern Oklahoma — Northeastern Health System-Sequoyah and Integris Grove Hospital — issued statements denying that they had been overrun by ivermectin users. During an interview, Scott Schaeffer, managing director of the Oklahoma Center for Poison and Drug Information, said that during August, his program had a total of 13…
Tag: Covid Treatments
Aesthetics Advisor reports “Hydroxychloroquine vs Ivermectin vs Quercetin: What are the Differences?”
If you are confused about the recommendations made by different professional groups for the COVID-19 pandemic, you’ve come to the right place. Before you continue to read this rather long article, let’s start with the end in mind and begin with the conclusion that you may have been told. There is no early treatment for…
One Day MD reports “Dr Richard Bartlett Inhaled Budesonide Protocol for COVID-19”
In April 2021, The Lancet reported evidence of UK’s first effective drug to treat COVID-19 in patients at home, inhaled budesonide, showing the treatment can reduce recovery time by a median of three days. The treatment has since been included in clinical guidelines for treating early-stage COVID-19 across the UK, Canada and India. Dr. Richard Bartlett shared…
Trial Site News reports “Ivermectin: Pros vs Cons. Dr. Luis Garegnani and Dr. Pierre Kory Debate The Issue”
Dr. Luis Garegnani from Argentia wrote an opinion piece on Ivermectin not having enough evidence behind it in BMJ Journals. Dr. Pierre Kory of the FLCCC disagrees. Both doctors debate this issue with Dr. Erin Stair as the moderator. About Luis Garegnani: Luis Garegnani is a Professor of Research methods and evidence-based medicine at Instituto…
Open Forum Infectious Disease reports “Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection”
Ivermectin is an antiparasitic drug being investigated for repurposing against SARS-CoV-2. Ivermectin showed in-vitro activity against SARS-COV-2 at high concentrations. This meta-analysis investigated ivermectin in 24 randomized clinical trials (3328 patients) identified through systematic searches of PUBMED, EMBASE, MedRxiv and trial registries. Ivermectin was associated with reduced inflammatory markers (C-Reactive Protein, d-dimer and ferritin) and…
Research Square reports “Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic”
Up-to-date, there is no recognized effective treatment or vaccine for the treatment of COVID-19 that emphasize urgency around distinctive effective therapies. This study aims to evaluate the anti-parasitic medication efficacy “Ivermectin” plus standard care ((Azithromycin, vitamin C, Zinc, Lactoferrin & Acetylcystein & prophylactic or therapeutic anticoagulation if D-dimer > 1000)) in the treatment of mild/moderate and severely…
FLCCC reports “The WHO’s Denial of Ivermectin: Big Science, Disinformation and their Impacts on Human Rights”
“The WHO is completely compromised,” says Dr. Kory. “They are protecting other interests.” The scale of the markets (think vaccines and pharmaceutical companies) that would be affected by the approval of ivermectin for the prevention and treatment of COVID-19 is massive. Meanwhile, because the WHO failed to recommend ivermectin for worldwide use, hundreds of thousands…
Mercola reports “More Good News on Ivermectin”
Ivermectin is an antiparasitic drug that may be even more useful against COVID-19 than hydroxychloroquine (HCQ). However, like HCQ, use of ivermectin has been globally suppressed, discouraged and even warned against, despite decades of safe use for other ailments In the U.S., the Frontline COVID-19 Critical Care Alliance (FLCCC) has been calling for widespread adoption…
Association of American Physicians and Surgeons reports “Peter McCullough, MD testifies to Texas Senate HHS Committee”
A testimony about the failure of public health to address COVID early treatments Transcript available here: https://www.jennifermargulis.net/peter-mccullough-md-compassion-crisis-in-medicine
Front Line COVID-19 Critical Care Alliance reports “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19”
In March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) was created and led by Professor Paul E. Marik to continuously review the rapidly emerging basic science, translational, and clinical data to develop a treatment protocol for COVID-19. The FLCCC then recently discovered thativermectin, an anti-parasitic medicine, has highly potent anti-viral and anti-inflammatory properties…